Our device can rapidly detect important cellular changes that other devices cannot
Sign up to see how you are connected to InVitroMetrix
There was a problem loading your content.
Our first device is for the research market, focused on disease modeling and drug discovery. The device and accompanying analytical software will permit real time culture monitoring with continuous data collection and will fit inside a standard culture incubator. We are in discussions with Thermo Fisher to develop a liver-disease modeling capability, which can be used for fibrosis drug discovery… · Morey and toxicology assessment.
Target Market: Our initial market will be the cell-based assay and reagent drug discovery market, which is estimated at $11.6B (2019, CAGR 11%). This market is segmented into Industrial Biopharma ($5.9B) and Pharmaceutical Research and Discovery ($5.7B). We are also addressing aspects of the biosensor market $28.8B (2021,CAGR 14%) and, in the longer term, the tumor biopsy market $11B (2016, CAGR 8.9%).